Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure

Abstract Aims Recent trials have evaluated sodium–glucose co‐transporter 2 inhibitors in patients with heart failure (HF). We sought to assess the robustness of findings from these trials using the fragility index (FI). Methods and results Fragility index is defined as the minimum number of patients...

Full description

Bibliographic Details
Main Authors: Muhammad Shariq Usman, Muhammad Shahzeb Khan, Gregg C. Fonarow, Stephen J. Greene, Tim Friede, Muthiah Vaduganathan, Gerasimos Filippatos, Andrew J. Stewart Coats, Stefan D. Anker, Javed Butler
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:ESC Heart Failure
Subjects:
Fragility index
Robustness
Sodium–glucose co‐transporter 2 inhibitors
Cardiac failure
Online Access:https://doi.org/10.1002/ehf2.13785

Internet

https://doi.org/10.1002/ehf2.13785

Similar Items